- Home
- HSON vs ATHA Comparison
HSON vs ATHA Comparison
Compare HSON & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSON
- ATHA
- Stock Information
- Founded
- HSON 1999
- ATHA 2011
- Country
- HSON United States
- ATHA United States
- Employees
- HSON N/A
- ATHA N/A
- Industry
- HSON Professional Services
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- HSON Consumer Discretionary
- ATHA Health Care
- Exchange
- HSON Nasdaq
- ATHA Nasdaq
- Market Cap
- HSON 26.1M
- ATHA 21.0M
- IPO Year
- HSON N/A
- ATHA 2020
- Fundamental
- Price
- HSON $10.20
- ATHA $0.25
- Analyst Decision
- HSON
- ATHA Buy
- Analyst Count
- HSON 0
- ATHA 4
- Target Price
- HSON N/A
- ATHA $11.25
- AVG Volume (30 Days)
- HSON 2.4K
- ATHA 202.0K
- Earning Date
- HSON 05-20-2025
- ATHA 05-14-2025
- Dividend Yield
- HSON N/A
- ATHA N/A
- EPS Growth
- HSON N/A
- ATHA N/A
- EPS
- HSON N/A
- ATHA N/A
- Revenue
- HSON $140,056,000.00
- ATHA N/A
- Revenue This Year
- HSON $1.16
- ATHA N/A
- Revenue Next Year
- HSON $7.71
- ATHA N/A
- P/E Ratio
- HSON N/A
- ATHA N/A
- Revenue Growth
- HSON N/A
- ATHA N/A
- 52 Week Low
- HSON $8.83
- ATHA $0.22
- 52 Week High
- HSON $19.70
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- HSON 53.15
- ATHA 43.26
- Support Level
- HSON $10.05
- ATHA $0.23
- Resistance Level
- HSON $10.74
- ATHA $0.31
- Average True Range (ATR)
- HSON 0.26
- ATHA 0.03
- MACD
- HSON 0.09
- ATHA 0.00
- Stochastic Oscillator
- HSON 71.73
- ATHA 30.00
About HSON Hudson Global Inc.
Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.